PMC:7371427 / 82663-83134
Annnotations
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1227 | 0-1 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T1228 | 19-21 | http://purl.obolibrary.org/obo/CLO_0051456 | denotes | AE |
T1229 | 41-42 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T1230 | 65-67 | http://purl.obolibrary.org/obo/CLO_0051456 | denotes | AE |
T1231 | 180-185 | http://purl.obolibrary.org/obo/UBERON_0002415 | denotes | tails |
T1232 | 262-263 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T1233 | 356-357 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T1234 | 379-380 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T1235 | 443-448 | http://purl.obolibrary.org/obo/UBERON_0002415 | denotes | tails |
T1236 | 453-454 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T51774 | 19-21 | Chemical | denotes | AE | http://purl.obolibrary.org/obo/CHEBI_61565 |
T34486 | 55-59 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T20869 | 65-67 | Chemical | denotes | AE | http://purl.obolibrary.org/obo/CHEBI_61565 |
T23032 | 99-103 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T93869 | 387-391 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T56311 | 466-470 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T512 | 0-186 | Sentence | denotes | A nice property of AE score is that, for a given query drug, the AE scores of the events with that drug turn out to roughly follow an exponential distribution, particularly at the tails. |
T513 | 187-261 | Sentence | denotes | We can then fit exponential distributions to the scores, and analyze them. |
T514 | 262-471 | Sentence | denotes | A benefit of the exponential fit is that we can make more robust claims about how significant a certain score is for a query drug, even if the empirical data is sparse/noisy at the tails for a particular drug. |